BioRegenx Past Earnings Performance
Past criteria checks 0/6
BioRegenx has been growing earnings at an average annual rate of 24.7%, while the Interactive Media and Services industry saw earnings growing at 6% annually. Revenues have been declining at an average rate of 137.9% per year.
Key information
24.7%
Earnings growth rate
40.9%
EPS growth rate
| Interactive Media and Services Industry Growth | 6.2% |
| Revenue growth rate | -137.9% |
| Return on equity | -6.1% |
| Net Margin | 240.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How BioRegenx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 0 | -1 | 0 | 0 |
| 31 Dec 23 | 0 | -1 | 0 | 0 |
| 30 Sep 23 | 3 | -2 | 4 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
| 30 Sep 22 | 3 | -5 | 6 | 0 |
| 31 Dec 21 | 4 | -5 | 6 | 0 |
| 31 Dec 20 | 8 | -1 | 6 | 0 |
Quality Earnings: BRGX is currently unprofitable.
Growing Profit Margin: BRGX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BRGX is unprofitable, but has reduced losses over the past 5 years at a rate of 24.7% per year.
Accelerating Growth: Unable to compare BRGX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BRGX is unprofitable, making it difficult to compare its past year earnings growth to the Interactive Media and Services industry (40.5%).
Return on Equity
High ROE: BRGX has a negative Return on Equity (-6.15%), as it is currently unprofitable.